Liraglutide

5 trials 2 recruiting AGastroenterology

Filter these 5 trials by condition, phase, country and more.

Open in Search →

5 Registered trials

2 Recruiting

3 Completed trials

4 Sponsors

7 Countries

Phase III

Phase II

Phase IV

Phase I (Other)

Phase III: 1 Phase II: 2 Phase IV: 1 Phase I (Other): 1

Oversight events:

1 temporary halt 1 unexpected event across 2 trials

View oversight register →

Indications tested

Obesity 2 Osteoarthritis 2 Synovitis 1 Overweight 1

Sponsors using this IMP

4moving Biotech 2 Novo Nordisk A/S 1 Pfizer Inc. 1 UZ Leuven 1

All trials

5 total

A study to learn about the efficacy and safety of 4P004 in participants with knee synovitis and osteoarthritis Recruiting

2024-518916-38-00 Phase II 4 countries 4moving Biotech
The effect of liraglutide on MMC activity, gastrointestinal hormones, hunger ratings and ad libitum food intake in healthy volunteers. Recruiting

2024-518641-21-00 Phase IV 1 country UZ Leuven
A research study on how well liraglutide works in children with obesity Ended

2023-508504-38-00 Phase III 2 countries Novo Nordisk A/S
A Study to Learn About the Study Medicine Called PF-07976016 in Adults With Obesity Ended

2024-513679-42-00 Phase II 2 countries Pfizer Inc.
Safety, tolerability and pharmacokinetics of intra‐articular (IA) single ascending dose of 4P‐004 in patient with Kellgren and Lawrence grad… Ended

2022-500271-31-00 Phase I (Other) 1 country 4moving Biotech

Showing 1–5 of 5 trials

← All drugs A–Z